| Target Validation Information | |||||
|---|---|---|---|---|---|
| Target ID | T28132 | ||||
| Target Name | Voltage-dependent calcium channel subunit alpha-2/delta-2 | ||||
| Target Type | Research |
||||
| Drug Potency against Target | 3-Aminomethyl-5-methyl-hexanoic acid | Drug Info | IC50 = 83 nM | ||
| PD-144550 | Drug Info | IC50 = 620 nM | |||
| The Effect of Target Knockout, Knockdown or Genetic Variations | The CACNA1A gene encodes the poreforming, voltage-sensitive subunit of the voltage-dependent Ca(v)2.1 calci uM channel. Mutations in this gene have been linked to several h uMandisorders, including familial hemiplegic migraine type 1, episodic ataxia type 2, and spinocerebellar ataxia type 6. In mice, mutations of the homolog Cacna1a cause recessively inherited phenotypes in tottering, rolling Nagoya, rocker, and leaner mice. Here we describe two knockdown mice with 28.4+/-3.4% and 13.8+/-3.3% of the wild-type Ca(v)2.1 quantity. 28.4+/-3.4% level mutants displayed ataxia, absence-like seizures and progressive cerebellar atrophy, although they had a normal life span. Mutants with 13.8+/-3.3% level exhibited ataxia severer than the 28.4+/-3.4% level mutants, absence-like seizures and additionally paroxysmal dyskinesia, and died premature around 3 weeks of age. These results indicate that knock down of Ca(v)2.1 quantity to 13.8+/-3.3% of the wild-type level are sufficient to induce the all neurological disorders observed in natural occurring Cacna1a mutants. These knockdown animals with Ca(v)2.1 calci uM channels intact can contribute to functional studies of the molecule in the disease. | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.